Corporate Tech Investors

BridgeBio Pharma

BridgeBio Pharma is a corporate entity that makes strategic investments in companies that are a good strategic fit.

Venture Investor Overview

Contact Information

Background Information

Overview

We are a collection of individuals focused on discovering and developing drugs for patients with grievous genetic diseases. We do this by: Finding the right starting points to target diseases at their source. Using a combination of a systematic assessment of the genetic disease landscape and informed diligence on the latest research, we find indications with clear mechanisms of pathogenesis that are ripe for translation into disease-modifying drugs.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

4/6/2018

Transaction History

Our records indicate that BridgeBio Pharma invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

Neil Kumar

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

BridgeBio Pharma has invested in only one tech company, according to our database records. If we are missing a portfolio company, please let us know.

Browse more corporate investors:

BRED Banque Populaire | Bridger Healthcare

Share this article

About Our Corporate Tech Investing Database

This corporate tech investor profile is powered by VentureDeal.com, a leading supplier of corporate VC funding data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary